BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hölscher AH, Stahl M, Messmann H, Stuschke M, Meyer HJ, Porschen R. [New S3 guideline for esophageal cancer : Important surgical aspects]. Chirurg 2016;87:865-72. [PMID: 27406251 DOI: 10.1007/s00104-016-0214-1] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
Number Citing Articles
1 Kemper M, Molwitz I, Krause L, Reeh M, Burdelski C, Kluge S, Yamamura J, Izbicki JR, de Heer G. Are muscle parameters obtained by computed tomography associated with outcome after esophagectomy for cancer? Clin Nutr 2021;40:3729-40. [PMID: 34130018 DOI: 10.1016/j.clnu.2021.04.040] [Reference Citation Analysis]
2 Favi F, Bollschweiler E, Berlth F, Plum P, Hescheler DA, Alakus H, Semrau R, Celik E, Mönig SP, Drebber U, Hölscher AH. Neoadjuvant chemotherapy or chemoradiation for patients with advanced adenocarcinoma of the oesophagus? A propensity score-matched study. Eur J Surg Oncol 2017;43:1572-80. [PMID: 28666624 DOI: 10.1016/j.ejso.2017.06.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
3 Beckert S, Königsrainer A. Oligometastasierung beim Magen- und Ösophaguskarzinom: Aktuelle Studienlage und chirurgische Konzepte. Chirurg 2018;89:505-9. [DOI: 10.1007/s00104-018-0645-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
4 Schmidt T, Mönig SP. [Therapeutic approach in oligometastatic gastric and esophageal cancer]. Chirurg 2017;88:1024-32. [PMID: 29098307 DOI: 10.1007/s00104-017-0548-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
5 Babic B, Müller DT, Gebauer F, Schiffmann LM, Datta RR, Schröder W, Bruns CJ, Leers JM, Fuchs HF. Gastrointestinal function testing model using a new laryngopharyngeal pH probe (Restech) in patients after Ivor-Lewis esophagectomy. World J Gastrointest Oncol 2021; 13(6): 612-624 [PMID: 34163577 DOI: 10.4251/wjgo.v13.i6.612] [Reference Citation Analysis]
6 Mönig S, Chevallay M, Niclauss N, Zilli T, Fang W, Bansal A, Hoeppner J. Early esophageal cancer: the significance of surgery, endoscopy, and chemoradiation. Ann N Y Acad Sci 2018;1434:115-23. [PMID: 30138532 DOI: 10.1111/nyas.13955] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
7 Hölscher AH, Babic B. New approaches in esophageal carcinomas. Innov Surg Sci 2016;1:87-95. [PMID: 31579724 DOI: 10.1515/iss-2016-0020] [Reference Citation Analysis]
8 Babic B, Fuchs HF, Bruns CJ. [Neoadjuvant chemoradiotherapy or chemotherapy for locally advanced esophageal cancer?]. Chirurg 2020;91:379-83. [PMID: 32140748 DOI: 10.1007/s00104-020-01150-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Chevallay M, Bollschweiler E, Chandramohan SM, Schmidt T, Koch O, Demanzoni G, Mönig S, Allum W. Cancer of the gastroesophageal junction: a diagnosis, classification, and management review. Ann N Y Acad Sci 2018;1434:132-8. [PMID: 30138540 DOI: 10.1111/nyas.13954] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
10 Münch S, Habermehl D, Agha A, Belka C, Combs SE, Eckel R, Friess H, Gerbes A, Nüssler NC, Schepp W, Schmid RM, Schmitt W, Schubert-Fritschle G, Weber B, Werner J, Engel J. Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma : A population-based evaluation of the Munich Cancer Registry. Strahlenther Onkol 2018;194:125-35. [PMID: 29071366 DOI: 10.1007/s00066-017-1225-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
11 Fuchs HF, Schmidt HM, Meissner M, Brinkmann S, Maus M, Bludau M, Schröder W, Hölscher AH, Leers JM. Endoscopic and histopathologic reflux-associated mucosal damage in the remnant esophagus following transthoracic esophagectomy for cancer-5-year long-term follow-up. Dis Esophagus 2018;31:1-6. [PMID: 29036607 DOI: 10.1093/dote/dox115] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
12 Tagkalos E, van der Sluis PC, Berlth F, Poplawski A, Hadzijusufovic E, Lang H, van Berge Henegouwen MI, Gisbertz SS, Müller-Stich BP, Ruurda JP, Schiesser M, Schneider PM, van Hillegersberg R, Grimminger PP. Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal adenocarcinoma, a randomized controlled trial (ROBOT-2 trial). BMC Cancer 2021;21:1060. [PMID: 34565343 DOI: 10.1186/s12885-021-08780-x] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Müller DT, Babic B, Herbst V, Gebauer F, Schlößer H, Schiffmann L, Chon SH, Schröder W, Bruns CJ, Fuchs HF. Does Circular Stapler Size in Surgical Management of Esophageal Cancer Affect Anastomotic Leak Rate? 4-Year Experience of a European High-Volume Center. Cancers (Basel) 2020;12:E3474. [PMID: 33266414 DOI: 10.3390/cancers12113474] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Fuchs HF, Müller DT, Leers JM, Schröder W, Bruns CJ. Modular step-up approach to robot-assisted transthoracic esophagectomy-experience of a German high volume center. Transl Gastroenterol Hepatol 2019;4:62. [PMID: 31559343 DOI: 10.21037/tgh.2019.07.04] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
15 Hölscher AH, Gockel I, Porschen R. [Updated German S3 guidelines on esophageal cancer and supplements from a surgical perspective]. Chirurg 2019;90:398-402. [PMID: 30976890 DOI: 10.1007/s00104-019-0954-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]